Genetic diversity and models of viral evolution for the hepatitis C virus

FEMS Microbiology Letters

Volumn 214, Issue 2, 2002, Pages 143-152

  Stumpf, M P H ^a   Pybus, O G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

RNA virus; Sequence evolution; Statistical genetics; Virus dynamics

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

DYNAMICS; GENE SEQUENCE; GENETIC MODEL; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; METHODOLOGY; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; POPULATION GENETICS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SHORT SURVEY; THEORY; TREATMENT OUTCOME; VIRUS GENE; VIRUS INFECTION;

HEPACIVIRUS; MODELS, GENETIC; PHYLOGENY; VARIATION (GENETICS);

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0037057124     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)00854-6     Document Type: Short Survey

References (57)

1. Organization WH (1995) Wkly. Epidemiol. Rec. In: Book Wkly. Epidemiol. Rec.
2. Prevention CfDCa (1998) Morb. Mortal. Wkly. Rep., 47, RR-19.
3. Kalinina O., Norder H., Mukomolov S., Magnius L.O. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J. Virol. 76:2002;4034-4043.
4. Eigen M. Self-organization of matter and the evolution of biological molecules. Naturwissenschaften. 58:1971;465-523.
5. Nowak, M.A. and May, R.M. (2000) Virus Dynamics. Oxford University Press, Oxford.
6. Domingo, E., Escarmis, C., Menendez-Arias, L. and Holland, J.J. (1999) Viral quasispecies and fitness variations. In: Origin and Evolution of Viruses (Domingo, E., Webster, R. and Holland, J.J., Eds.), Academic Press, San Diego, CA, pp. 141-162.
7. de la Torre J.C., Holland J.J. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:1990;6278-6281.
8. Holmes E.C., Moya A. Is the quasispecies concept relevant to RNA viruses? J. Virol. 76:2002;460-465.
9. Rosenberg N.A., Nordborg M. Genealogical trees, coalescent theory and the analysis of genetic polymorphisms. Nat. Rev. Genet. 3:2002;380-390.
10. Li, W.H. (1997) Molecular Evolution. Sinauer, Sunderland.
11. Hartl, D.L. and Clark, A.G. (1998) Principles of Population Genetics, 3rd Edn. Sinauer, Sunderland.
12. Kimura M. Evolutionary Rate at the molecular level. Nature. 217:1968;624-626.
13. Ohta T. Slightly deleterious substitutions in evolution. Nature. 246:1973;96-98.
14. Swofford, D.L., Olsen, G.J., Waddell, P.J. and Hillis, D.M. (1999) Phylogenetic inference. In: Molecular Systematics (Hillis, D.M., Mable, B.K. and Moritz, C., Eds.), pp. 407-543. Sinauer, Sunderland.
15. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymus and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:1986;418-426.
16. Yang Z., Nielsen R., Goldman N., Pedersen A.M. Codon-substitutions models for heterogeneous selection pressure at amino acid sites. Genetics. 155:2000;431-449.
17. Crandall K.A., Kelsey C.R., Imamichi H., Lane H.C., Salzman N.P. Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol. Biol. Evol. 16:1999;372-382.
18. Robertson B., Myers G., Howard C., Brettin T., Bukh J., Gaschen B., Gojobori T., Maertens G., Mizokami M., Nainan O., Robertson B., Netesov S., Nishioka K., Shin-i T., Simmonds P., Smith D., Stuyver L., Weiner A. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol. 143:1998;2493-2503.
19. Simmonds, P. (2000) Hepatitis C virus genotypes. In: Hepatitis C (Liang, T.J. and Hoofnagle, J.H., Eds.), pp. 53-83. Academic Press, London.
20. Salemi M., Vandamme A.M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 54:2002;62-70.
21. Mondelli M.U., Silini E. Clinical significance of hepatitis C virus genotypes. J. Hepatol. 31:(Suppl. 1):1999;65-70.
22. Smith D.B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P.L., Simmonds P. The origin of hepatitis C virus genotypes. J. Gen. Virol. 78:1997;321-328.
23. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V., Mukomolov S., Magnius L.O. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J. Med. Virol. 65:2001;517-524.
24. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., Harvey P.H. The epidemic behavior of the hepatitis C virus. Science. 292:2001;2323-2325.
25. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., El Khoby T., Abdel Wahab Y., Aly Ohn E.S., Anwar W., Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 355:2000;887-891.
26. Bell H., Hellum K., Harthug S., Maeland A., Ritland S., Myrvang B., von der Lippe B., Raknerud N., Skaug K., Gutigard B.G., Skjaerven R., Prescott L.E., Simmonds P. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand. J. Infect. Dis. 29:1997;17-22.
27. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96:1995;224-230.
28. Zeuzem S., Lee J.H., Roth W.K. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology (Baltimore, MD). 25:1997;740-744.
29. Boothe J.C., Foster G.R., Levine T., Thomas H.C., Goldin R.D. The relationship of histology in chronic HCV infection. Liver. 17:1997;144-151.
30. Kleter B., Brouwer J.T., Nevens F., van Doorn L.J., Elewaut A., Versieck J., Michielsen P.P., Hautekeete M.L., Chamuleau R.A., Brenard R., Bourgeois N., Adler M., Quint W.G., Bronkhorst C.M., Heijtink R.A., Hop W.J., Fevery W.J., Schalm S.W. Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver. 18:1998;32-38.
31. Takada A., Tsutsumi M., Zhang S.C., Okanoue T., Matsushima T., Fujiyama S., Komatsu M. Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: a nationwide analysis. J. Gastroenterol. Hepatol. 11:1996;166-169.
32. Laskus T., Radkowski M., Wang L.F., Nowicki M., Rakela J. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J. Virol. 74:2000;1014-1017.
33. Jang S.J., Wang L.F., Radkowski M., Rakela J., Laskus T. Differences between hepatitis C virus 5′ untranslated region quasispecies in serum and liver. J. Gen. Virol. 80:1999;711-716.
34. Navas S., Martin J., Quiroga J.A., Castillo I., Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J. Virol. 72:1998;1640-1646.
35. Radkowski M., Wilkinson J., Nowicki M., Adair D., Vargas H., Ingui C., Rakela J., Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 76:2002;600-608.
36. Cabot B., Gomez J., Martel M., Esteban J.I., Otero T., Esteban R., Guardia J. Evolution of replicating and circulating hepatitis C virus quasispecies in non-progressive chronic hepatitis C. Hepatology. 32:2000;414.
37. Afonso A.M.R., Jiang J.J., Penin F., Tareau C., Samuel D., Petit M.A., Bismuth H., Dussaix E., Feray C. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J. Virol. 73:1999;9213-9221.
38. Honda M., Kaneko S., Sakai A., Unoura M., Murakami S., Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology (Baltimore, MD). 20:1994;1144-1151.
39. Cabot B., Martell M., Esteban J.I., Sauleda S., Otero T., Esteban R., Guardia J., Gomez J. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J. Virol. 74:2000;805-811.
40. Stumpf M.P.H., Zitzmann N. RNA replication kinetics, genetic polymorphism and selection in the case of the hepatitis C virus. Proc. R. Soc. Lond. Ser. B Biol. Sci. 268:2001;1993-1999.
41. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 288:2000;339-344.
42. Lopez-Labrador F.X., Ampurdanes S., Gimenez-Barcons M., Guilera F.X., Costa J., de Anta M.T.J., Sanchez-Tapias J.M., Rodes J., Saiz J.C. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon. Hepatology. 29:1999;897-903.
43. Curran R., Jameson C.L., Craggs J.K., Grabowska A.M., Thomson B.J., Robins A., Irving W.L., Ball J.K. Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver severity. J. Gen. Virol. 83:2002;11-23.
44. Doughty A.L., Painter D.M., McCaughan G.W. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J. Hepatol. 32:2000;126-134.
45. Herrmann E., Neumann A.U., Schmidt J.M., Zeuzem S. Hepatitis C virus kinetics. Antiviral Ther. 5:2000;85-90.
46. Poynard T., Marcellin P., Lee S.S., Niederau C., Minuk G.S., Ideo G., Bain V., Heathcote J., Zeuzem S., Trepo C., Albrecht J. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 352:1998;1426-1432.
47. Farci P., Strazzera R., Alter H.J., Farci S., Degioannis D., Coiana A., Peddis G., Usai F., Serra G., Chezza L., Diaz G., Balestrieri A., Purcell R.H. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. USA. 99:2002;3081-3086.
48. Farci P., Strazzera R., DeGjonnis D., Peddis G., Chessa L., Setzu R., Ghiani A., Coiana A., Wong D., Balestrieri A., Purcell R.H. Evolution of the viral quasispecies tracked by sequence analysis during interferon treatment of chronic hepatitis C. Hepatology. 28:1998;938.
49. Sandres K., Dubois M., Pasquier C., Payen J.L., Alric L., Duffaut M., Vinel J.P., Pascal J.P., Puel J., Izopet J. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. J. Virol. 74:2000;661-668.
50. Hino K., Yamaguchi Y., Fujiwara D., Katoh Y., Korenaga M., Okazaki M., Okuda M., Okita K. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J. Viral Hepatitis. 7:2000;36-42.
51. Thelu M.A., Brengel-Pesce K., Leroy V., Attuil V., Drouet E., Seigneurin J.M., Zarski J.P. Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients. J. Med. Virol. 65:2001;698-705.
52. McKechnie V.M., Mills P.R., McCruden E.A.B. The NS5a gene of hepatitis C virus in patients treated with interferon-α J. Med. Virol. 60:2000;367-378.
53. Sanchez-Fueyo A., Gimenez-Barcons M., Puig-Basagoiti F., Rimola A., Sanchez-Tapias J.M., Saiz J.C., Rodes J. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J. Med. Virol. 65:2001;266-275.
54. Lawal Z., Petrik J., Wong V.S., Alexander G.J., Allain J.P. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology. 228:1997;107-111.
55. Ni Y.H., Chang M.H., Chen P.J., Hsu H.Y., Lu T.W., Lin K.H., Lin D.T. Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation. J. Med. Virol. 58:1999;132-138.
56. McMichael A.J., Rowland-Jones S.L. Cellular immune response to HIV. Nature. 410:2001;980-987.
57. Holmes E.C. On the origin and evolution of the human immunodefiency virus (HIV). Biol. Rev. 76:2001;239-254.